Wells Fargo’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Wells Fargo’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1	Closed	-$10	–	7769
2023 Q2	$10	Hold	1	–	–	﹤0.01%	7455
2023 Q1	$10	Hold	1	–	–	﹤0.01%	7511
2022 Q4	$10	Hold	1	–	–	﹤0.01%	7377
2022 Q3	$0	Buy	+1	New	+$10	﹤0.01%	7712

Wells Fargo's MTACU Position: Q3 2023 in Review

Wells Fargo sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2023, closing a stake of 1 share — an estimated $10 sold.

Wells Fargo first reported a position in MTACU in Q3 2022 and held it in 4 quarters. The position peaked at $10 in Q2 2023. 0 funds tracked by Wall St. Rank hold MTACU as of Q3 2023.

Wells Fargo reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2023 after selling out during the quarter.
Wells Fargo sold 1 MedTech Acquisition Corporation Unit share in Q3 2023, an estimated $10.
Wells Fargo first reported a position in MedTech Acquisition Corporation Unit in Q3 2022 and held it in 4 quarters.
Wells Fargo's MedTech Acquisition Corporation Unit position peaked at $10 in Q2 2023.
0 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2023.

Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.